This is reinforced by studies demonstrating that PTGER2 in ovarian cancer is identified as an oncogene that promotes cancer stem cell properties and resistance to chemotherapy, resulting in poor prognosis [29]. The gene discussed is PTGER2; the disease is ovarian carcinoma.